世界のフィナステリド経口錠剤市場予測（～2028年）：1mg錠、5mg錠

• 英文タイトル：Global Finasteride Oral Tablet Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8821 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

フィナステリド経口錠剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のフィナステリド経口錠剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 フィナステリド経口錠剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・1mg錠、5mg錠 用途別セグメントは次のように区分されます。 ・良性前立腺肥大症、男性型脱毛症、その他 世界のフィナステリド経口錠剤市場の主要な市場プレーヤーは以下のとおりです。 ・Merck、Accord Healthcare UK、Relonchem、Sandoz、Teva Generics、Cipla、Dr. Reddy、Aurobindo Pharma、Henan Topfond、Zhejiang CONBA Pharmaceutical、Shandong Renhetang Pharmaceutical、Guangdong Eashu Pharmacetical、Shanghai Shyndec Pharmaceutical Co.,Ltd. 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、フィナステリド経口錠剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なフィナステリド経口錠剤メーカーの企業概要、2019年～2022年までのフィナステリド経口錠剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なフィナステリド経口錠剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別フィナステリド経口錠剤の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのフィナステリド経口錠剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのフィナステリド経口錠剤市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびフィナステリド経口錠剤の産業チェーンを掲載しています。 ・第13、14、15章では、フィナステリド経口錠剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merck、Accord Healthcare UK、Relonchem、Sandoz、Teva Generics、Cipla、Dr. Reddy、Aurobindo Pharma、Henan Topfond、Zhejiang CONBA Pharmaceutical、Shandong Renhetang Pharmaceutical、Guangdong Eashu Pharmacetical、Shanghai Shyndec Pharmaceutical Co.,Ltd. ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：1mg錠、5mg錠 ・用途別分析2017年-2028年：良性前立腺肥大症、男性型脱毛症、その他 ・フィナステリド経口錠剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・フィナステリド経口錠剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・フィナステリド経口錠剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・フィナステリド経口錠剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・フィナステリド経口錠剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Finasteride Oral Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Finasteride Oral Tablet market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Benign Prostatic Hyperplasia accounting for % of the Finasteride Oral Tablet global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 1mg Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Finasteride Oral Tablet include Merck, Accord Healthcare UK, Relonchem, Sandoz, and Teva Generics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Finasteride Oral Tablet market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
1mg Tablet
5mg Tablet
Market segment by Application can be divided into
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
The key market players for global Finasteride Oral Tablet market are listed below:
Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Finasteride Oral Tablet product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Finasteride Oral Tablet, with price, sales, revenue and global market share of Finasteride Oral Tablet from 2019 to 2022.
Chapter 3, the Finasteride Oral Tablet competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Finasteride Oral Tablet breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Finasteride Oral Tablet market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Finasteride Oral Tablet.
Chapter 13, 14, and 15, to describe Finasteride Oral Tablet sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Finasteride Oral Tablet Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Finasteride Oral Tablet Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Finasteride Oral Tablet Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Benign Prostatic Hyperplasia
1.3.3 Male Pattern Baldness
1.3.4 Others
1.4 Global Finasteride Oral Tablet Market Size & Forecast
1.4.1 Global Finasteride Oral Tablet Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Finasteride Oral Tablet Sales in Volume (2017-2028)
1.4.3 Global Finasteride Oral Tablet Price (2017-2028)
1.5 Global Finasteride Oral Tablet Production Capacity Analysis
1.5.1 Global Finasteride Oral Tablet Total Production Capacity (2017-2028)
1.5.2 Global Finasteride Oral Tablet Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Finasteride Oral Tablet Market Drivers
1.6.2 Finasteride Oral Tablet Market Restraints
1.6.3 Finasteride Oral Tablet Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Finasteride Oral Tablet Product and Services
2.1.4 Merck Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Accord Healthcare UK
2.2.1 Accord Healthcare UK Details
2.2.2 Accord Healthcare UK Major Business
2.2.3 Accord Healthcare UK Finasteride Oral Tablet Product and Services
2.2.4 Accord Healthcare UK Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Relonchem
2.3.1 Relonchem Details
2.3.2 Relonchem Major Business
2.3.3 Relonchem Finasteride Oral Tablet Product and Services
2.3.4 Relonchem Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business
2.4.3 Sandoz Finasteride Oral Tablet Product and Services
2.4.4 Sandoz Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Teva Generics
2.5.1 Teva Generics Details
2.5.2 Teva Generics Major Business
2.5.3 Teva Generics Finasteride Oral Tablet Product and Services
2.5.4 Teva Generics Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Finasteride Oral Tablet Product and Services
2.6.4 Cipla Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Dr. Reddy
2.7.1 Dr. Reddy Details
2.7.2 Dr. Reddy Major Business
2.7.3 Dr. Reddy Finasteride Oral Tablet Product and Services
2.7.4 Dr. Reddy Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Finasteride Oral Tablet Product and Services
2.8.4 Aurobindo Pharma Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Henan Topfond
2.9.1 Henan Topfond Details
2.9.2 Henan Topfond Major Business
2.9.3 Henan Topfond Finasteride Oral Tablet Product and Services
2.9.4 Henan Topfond Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Zhejiang CONBA Pharmaceutical
2.10.1 Zhejiang CONBA Pharmaceutical Details
2.10.2 Zhejiang CONBA Pharmaceutical Major Business
2.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product and Services
2.10.4 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shandong Renhetang Pharmaceutical
2.11.1 Shandong Renhetang Pharmaceutical Details
2.11.2 Shandong Renhetang Pharmaceutical Major Business
2.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product and Services
2.11.4 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Guangdong Eashu Pharmacetical
2.12.1 Guangdong Eashu Pharmacetical Details
2.12.2 Guangdong Eashu Pharmacetical Major Business
2.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product and Services
2.12.4 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
2.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Details
2.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Major Business
2.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product and Services
2.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Finasteride Oral Tablet Breakdown Data by Manufacturer
3.1 Global Finasteride Oral Tablet Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Finasteride Oral Tablet Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Finasteride Oral Tablet
3.4 Market Concentration Rate
3.4.1 Top 3 Finasteride Oral Tablet Manufacturer Market Share in 2021
3.4.2 Top 6 Finasteride Oral Tablet Manufacturer Market Share in 2021
3.5 Global Finasteride Oral Tablet Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Finasteride Oral Tablet Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Finasteride Oral Tablet Market Size by Region
4.1.1 Global Finasteride Oral Tablet Sales in Volume by Region (2017-2028)
4.1.2 Global Finasteride Oral Tablet Revenue by Region (2017-2028)
4.2 North America Finasteride Oral Tablet Revenue (2017-2028)
4.3 Europe Finasteride Oral Tablet Revenue (2017-2028)
4.4 Asia-Pacific Finasteride Oral Tablet Revenue (2017-2028)
4.5 South America Finasteride Oral Tablet Revenue (2017-2028)
4.6 Middle East and Africa Finasteride Oral Tablet Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Finasteride Oral Tablet Sales in Volume by Type (2017-2028)
5.2 Global Finasteride Oral Tablet Revenue by Type (2017-2028)
5.3 Global Finasteride Oral Tablet Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Finasteride Oral Tablet Sales in Volume by Application (2017-2028)
6.2 Global Finasteride Oral Tablet Revenue by Application (2017-2028)
6.3 Global Finasteride Oral Tablet Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Finasteride Oral Tablet Sales by Type (2017-2028)
7.2 North America Finasteride Oral Tablet Sales by Application (2017-2028)
7.3 North America Finasteride Oral Tablet Market Size by Country
7.3.1 North America Finasteride Oral Tablet Sales in Volume by Country (2017-2028)
7.3.2 North America Finasteride Oral Tablet Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Finasteride Oral Tablet Sales by Type (2017-2028)
8.2 Europe Finasteride Oral Tablet Sales by Application (2017-2028)
8.3 Europe Finasteride Oral Tablet Market Size by Country
8.3.1 Europe Finasteride Oral Tablet Sales in Volume by Country (2017-2028)
8.3.2 Europe Finasteride Oral Tablet Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Finasteride Oral Tablet Sales by Type (2017-2028)
9.2 Asia-Pacific Finasteride Oral Tablet Sales by Application (2017-2028)
9.3 Asia-Pacific Finasteride Oral Tablet Market Size by Region
9.3.1 Asia-Pacific Finasteride Oral Tablet Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Finasteride Oral Tablet Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Finasteride Oral Tablet Sales by Type (2017-2028)
10.2 South America Finasteride Oral Tablet Sales by Application (2017-2028)
10.3 South America Finasteride Oral Tablet Market Size by Country
10.3.1 South America Finasteride Oral Tablet Sales in Volume by Country (2017-2028)
10.3.2 South America Finasteride Oral Tablet Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Finasteride Oral Tablet Sales by Type (2017-2028)
11.2 Middle East & Africa Finasteride Oral Tablet Sales by Application (2017-2028)
11.3 Middle East & Africa Finasteride Oral Tablet Market Size by Country
11.3.1 Middle East & Africa Finasteride Oral Tablet Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Finasteride Oral Tablet Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Finasteride Oral Tablet and Key Manufacturers
12.2 Manufacturing Costs Percentage of Finasteride Oral Tablet
12.3 Finasteride Oral Tablet Production Process
12.4 Finasteride Oral Tablet Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Finasteride Oral Tablet Typical Distributors
13.3 Finasteride Oral Tablet Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---